perindopril has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YP; Shih, PY | 1 |
| Chai, SY; Horne, MK; Mendelsohn, FA; Reardon, KA | 1 |
1 trial(s) available for perindopril and Parkinson Disease
| Article | Year |
|---|---|
The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Double-Blind Method; Humans; Levodopa; Middle Aged; Parkinson Disease; Perindopril; Pilot Projects | 2000 |
1 other study(ies) available for perindopril and Parkinson Disease
| Article | Year |
|---|---|
A case of Parkinson's disease worsened by captopril: an unexpected adverse effect.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Diseases; Humans; Parkinson Disease; Perindopril | 2009 |